CXL Ophthalmics’ $32 Million Series A Round of Fundraising

Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts.CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive treatment…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here